Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Is the Smoldering NASH Market Ready to Burst Into Flames?

Although Intercept appears ahead, Gilead Sciences, GENFIT and Allergan all have NASH products in Phase III clinical trials. However, in a November 2018 article, Steven Seedhouse, an analyst with Raymond James, told BioPharma Dive, “None of these drugs are so effective that it is clearly going to own the market. There’s room to improve on response rates and, because most of these drugs are pills, there’s room to combine them.”

https://www.biospace.com/article/is-the-smoldering-nash-market-ready-to-burst-into-flames-/

Anyone think 84% is a mediocre result?

Nash Pharmaceuticals Announces 84% Reduction of Fibrosis by Additional Lead Compound In Second Pre-Clinical Study For Non-Alcoholic Fatty Liver Disease

NASH Disease ~ Is ~ The New Frontier





Click For BTHCF Price Target


/////AMG